Since several surface PAD4-increasing stimuli are elevated in the serum of patients with RA or SLE (e.g., TNF-α, GM-CSF, IC), we hypothesize that surface PAD4 could be upregulated in those patients. This evidence concerns the gene CSF2 and systemic lupus erythematosus.